McAlpine JN - Search Results

1

Variability in endometrial carcinoma pathology practice: opportunities for improvement with molecular classification.

Thompson EF, Huvila J, Jamieson A, Leung S, Lum A, Offman S, Lytwyn A, Sur ML, Hoang L, Irving J, van der Westhuizen N, Morin C, Bicamumpaka C, Azordegan N, Gougeon F, Ennour-Idrissi K, Senz J, McConechy MK, Aguirre-Hernandez R, Lui V, Kuo C, Bell C, Salisbury T, Lawson J, He E, Wang S, Chiu D, Kean S, Samouëlian V, Salvador S, Gotlieb W, Helpman L, Scott S, Wohlmuth C, Vicus D, Plante M, Talhouk A, Huntsman D, Parra-Herran C, Kinloch M, Grondin K, Gilks CB, McAlpine JN; Society of Gynecologic Oncologists of Canada (CoP, Translational Research). Thompson EF, et al. Among authors: mcalpine jn. Mod Pathol. 2022 Dec;35(12):1974-1982. doi: 10.1038/s41379-022-01165-w. Epub 2022 Oct 14. Mod Pathol. 2022. PMID: 36241860 Free article.

2

Xenografts of primary human gynecological tumors grown under the renal capsule of NOD/SCID mice show genetic stability during serial transplantation and respond to cytotoxic chemotherapy.

Press JZ, Kenyon JA, Xue H, Miller MA, De Luca A, Miller DM, Huntsman DG, Gilks CB, McAlpine JN, Wang YZ. Press JZ, et al. Among authors: mcalpine jn. Gynecol Oncol. 2008 Aug;110(2):256-64. doi: 10.1016/j.ygyno.2008.03.011. Epub 2008 Jun 10. Gynecol Oncol. 2008. PMID: 18547621

3

HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy.

McAlpine JN, Wiegand KC, Vang R, Ronnett BM, Adamiak A, Köbel M, Kalloger SE, Swenerton KD, Huntsman DG, Gilks CB, Miller DM. McAlpine JN, et al. BMC Cancer. 2009 Dec 10;9:433. doi: 10.1186/1471-2407-9-433. BMC Cancer. 2009. PMID: 20003286 Free PMC article.

4

Tumor growth inhibition by olaparib in BRCA2 germline-mutated patient-derived ovarian cancer tissue xenografts.

Kortmann U, McAlpine JN, Xue H, Guan J, Ha G, Tully S, Shafait S, Lau A, Cranston AN, O'Connor MJ, Huntsman DG, Wang Y, Gilks CB. Kortmann U, et al. Among authors: mcalpine jn. Clin Cancer Res. 2011 Feb 15;17(4):783-91. doi: 10.1158/1078-0432.CCR-10-1382. Epub 2010 Nov 19. Clin Cancer Res. 2011. PMID: 21097693

5

Autofluorescence imaging can identify preinvasive or clinically occult lesions in fallopian tube epithelium: a promising step towards screening and early detection.

McAlpine JN, El Hallani S, Lam SF, Kalloger SE, Luk M, Huntsman DG, MacAulay C, Gilks CB, Miller DM, Lane PM. McAlpine JN, et al. Gynecol Oncol. 2011 Mar;120(3):385-92. doi: 10.1016/j.ygyno.2010.12.333. Epub 2011 Jan 14. Gynecol Oncol. 2011. PMID: 21237503

6

Subtype-specific mutation of PPP2R1A in endometrial and ovarian carcinomas.

McConechy MK, Anglesio MS, Kalloger SE, Yang W, Senz J, Chow C, Heravi-Moussavi A, Morin GB, Mes-Masson AM; Australian Ovarian Cancer Study Group; Carey MS, McAlpine JN, Kwon JS, Prentice LM, Boyd N, Shah SP, Gilks CB, Huntsman DG. McConechy MK, et al. Among authors: mcalpine jn. J Pathol. 2011 Apr;223(5):567-73. doi: 10.1002/path.2848. Epub 2011 Mar 7. J Pathol. 2011. PMID: 21381030

7

The significance of surgical staging in intermediate-risk endometrial cancer.

Kwon JS, Mazgani M, Miller DM, Ehlen T, Heywood M, McAlpine JN, Finlayson SJ, Plante M, Stuart GC, Carey MS. Kwon JS, et al. Among authors: mcalpine jn. Gynecol Oncol. 2011 Jul;122(1):50-4. doi: 10.1016/j.ygyno.2011.02.037. Epub 2011 Mar 21. Gynecol Oncol. 2011. PMID: 21421262

8

Preoperative bowel preparation in gynecologic oncology: a review of practice patterns and an impetus to change.

Wells T, Plante M, McAlpine JN; Communities of Practice Groups on behalf of the Society of Gynecologic Oncologists of Canada. Wells T, et al. Among authors: mcalpine jn. Int J Gynecol Cancer. 2011 Aug;21(6):1135-42. doi: 10.1097/IGC.0b013e31821778c4. Int J Gynecol Cancer. 2011. PMID: 21633305

9

Frequency of known gene rearrangements in endometrial stromal tumors.

Chiang S, Ali R, Melnyk N, McAlpine JN, Huntsman DG, Gilks CB, Lee CH, Oliva E. Chiang S, et al. Among authors: mcalpine jn. Am J Surg Pathol. 2011 Sep;35(9):1364-72. doi: 10.1097/PAS.0b013e3182262743. Am J Surg Pathol. 2011. PMID: 21836477

10

BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinoma.

McAlpine JN, Porter H, Köbel M, Nelson BH, Prentice LM, Kalloger SE, Senz J, Milne K, Ding J, Shah SP, Huntsman DG, Gilks CB. McAlpine JN, et al. Mod Pathol. 2012 May;25(5):740-50. doi: 10.1038/modpathol.2011.211. Epub 2012 Jan 27. Mod Pathol. 2012. PMID: 22282309 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

174 results

Search Page